SCHEMBL11779657

SCHEMBL11779657

c1ccc(OCc2ncc[nH]2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 7/20 0.56
RAB9A P51151 4/20 0.53
TSHR P16473 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
NPC1 O15118 2/20 0.53
TP53 P04637 1/20 0.53
CYP2D6 P10635 1/20 0.46
NISCH Q9Y2I1 2/20 0.46
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
KCNH2 Q12809 1/20 0.46
DAO P14920 1/20 0.45
LMNA P02545 1/20 0.45
GLA P06280 1/20 0.45
BLM P54132 1/20 0.45
PMP22 Q01453 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
CYSLTR2 Q9NS75 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5758318 0.81 TAAR1 (0.41) TAAR1RAB9ATSHRSMN1; SMN2NPC1
SCHEMBL3979810 0.81 MAOB (0.43) TAAR1RAB9ASMN1; SMN2NPC1CYP2D6
SCHEMBL16313542 0.81 NPC1 (0.53) TAAR1RAB9ASMN1; SMN2NPC1CYP2D6
SCHEMBL8112160 0.81 TAAR1 (0.41) TAAR1RAB9ATSHRSMN1; SMN2NPC1
SCHEMBL11581355 0.81 TAAR1 (0.53) TAAR1TSHRSMN1; SMN2CYP2D6LMNA
SCHEMBL3979574 0.80 SMN1; SMN2 (0.58) TAAR1RAB9ATSHRSMN1; SMN2NPC1
SCHEMBL8108136 0.80 TAAR1 (0.41) TAAR1RAB9ATSHRSMN1; SMN2NPC1
SCHEMBL7508077 0.79 TAAR1 (0.42) TAAR1RAB9ATSHRSMN1; SMN2NPC1
SCHEMBL11760408 0.79 MAOB (0.49) TAAR1RAB9ASMN1; SMN2MAOBLMNA
SCHEMBL11702882 0.79 TAAR1 (0.73) TAAR1RAB9ATSHRSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4086242-B1 5-[(2,4-DINITROPHENOXY)METHYL]-1-METHYL-2-NITRO-L H-IMIDAZOLE AND ITS PHARMACEUTICAL USE RIVUS PHARMACEUTICALS INC (US) 2026-04-08 EP disclosed
US-8492556-B2 2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators ALLERGAN, INC. (US) 2013-07-23 US disclosed
CN-101421247-B imidazole derivatives, process for their preparation and their use as medicaments IPSEN PHARMA SAS 2011-06-15 CN disclosed
US-7572921-B2 Substituted benzylimidazoles useful for the treatment of inflammatory diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-08-11 US disclosed
CN-101421247-A Novel imidazole derivatives, process for their preparation and their use as medicaments SOD CONSEILS RECH APPLIC (FR) 2009-04-29 CN disclosed
CN-1795179-A Novel imidazole derivatives, the production thereof, and the use of the same as a medicament SOD CONSEILS RECH APPLIC (FR) 2006-06-28 CN disclosed
CN-1477960-A EPA receptor inhibitors to treat rheumatoid arthritis 2004-02-25 CN disclosed
US-4031232-A 1-Alkyl-2-(phenoxymethyl)-5-nitro-imidazoles and process for their manufacture HOECHST AKTIENGESELLSCHAFT (DT) 1977-06-21 US disclosed